EQS-News: SynBiotic SE / Key word (s): Miscellaneous In full bloom: WEECO Pharma boosts SYNBIOTIC's sales 14.11.2024 / 13:30 CET/CEST The issuer is solely responsible for the content of this ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...
Hosted on MSN14h
Brookline Capital Downgrades Syros Pharmaceuticals (SYRS)Avidity Partners Management holds 1,674K shares representing 6.24% ownership of the company. No change in the last quarter.
Hosted on MSN14h
TD Cowen Downgrades Syros Pharmaceuticals (SYRS)Avidity Partners Management holds 1,674K shares representing 6.24% ownership of the company. No change in the last quarter.
The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma ...
VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. (Eupraxia or the Company) (TSX: EPRX) (NASDAQ: EPRX ...
President Biden and Vice President Kamala Harris pretended to be anti-pharma but have taken over $10 million combined from ...
From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...
I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.
Pharmaceutical companies can benefit from the FDA Fast Track and Accelerated Approval ... DSI provides regulatory, technical, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback